TSE:BIOV Stock Latest News
Company AnnouncementsBioVaxys Updates Market on Cease Trade Order and Delayed Filings6M ago
Company AnnouncementsBioVaxys Updates on Filing Delays as Executives Face Trading Restrictions7M ago
Company AnnouncementsBioVaxys Extends Financial Filing Delay Under Management Cease Trade Order7M ago
Company AnnouncementsBioVaxys and Adiverna Team Up on AI-Driven mRNA Vaccines for Pets7M ago
Company AnnouncementsBioVaxys Applies for Management Cease Trade Order After Audit-Related Filing Delay8M ago
Company AnnouncementsBioVaxys Cancer Vaccine Combo Shows Durable Responses in Recurrent Ovarian Cancer Trial9M agoCompany AnnouncementsBioVaxys Advances DPX Vaccine Platform With New Collaborations and Positive Trial Data9M ago
Company AnnouncementsBioVaxys Posts Strong Phase 1 Data for DPX Cancer Vaccines in Bladder Cancer9M ago
Company AnnouncementsBioVaxys Sharpens DPX Vaccine Strategy With New Leadership and Positive Breast Cancer Data10M ago
Company AnnouncementsBioVaxys Reports Promising Phase 1 Results for Breast Cancer Treatment MVP-S10M ago
Company AnnouncementsBioVaxys Enhances Scientific Team with New Advisor10M ago
Company AnnouncementsBioVaxys Technology Completes Debt Settlement with Share Issuance11M ago
Company AnnouncementsBioVaxys Technology Secures $1.92 Million to Boost Immunotherapy Pipeline11M ago
Company AnnouncementsBioVaxys Upsizes Private Placement to Boost Immunotherapy Pipeline1y ago
Company AnnouncementsBioVaxys Converts Debentures into Equity, Strengthening Financial Position1y ago
Company AnnouncementsBioVaxys Converts Debentures to Strengthen Financial Position1y ago- Company AnnouncementsBioVaxys Converts Debentures and Grants Stock Options to Strengthen Market Position1y ago
Company AnnouncementsBioVaxys Reports Positive Results for SpayVac Immunocontraceptive Vaccine1y agoCompany AnnouncementsBioVaxys Technology Corp. Launches Private Placement to Boost Immunotherapy Pipeline1y ago
